ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

WHO diagnostic criteria atypical chronic myeloid leukemia, BCR-ABL1 negative

WHO diagnostic criteria atypical chronic myeloid leukemia, BCR-ABL1 negative
  • Peripheral blood leukocytosis due to increased numbers of neutrophils and their precursors (promyelocytes, myelocytes, metamyelocytes) comprising ≥10% of leukocytes
  • Dysgranulopoiesis, which may include abnormal chromatin clumping
  • No or minimal absolute basophilia; basophils usually <2% of leukocytes
  • No or minimal absolute monocytosis; monocytes <10% of leukocytes
  • Hypercellular bone marrow with granulocytic proliferation and granulocytic dysplasia, with or without dysplasia in the erythroid and megakaryocytic lineages
  • <20% blasts in the blood and bone marrow 
  • No evidence of PDGFRA, PDGFRB, or FGFR1 rearrangement, or PCM1-JAK2
  • Not meeting WHO criteria for BCR-ABL1+ CML, PMF, PV, or ET*
Diagnosis of atypical CML, BCR-ABL1- requires meeting all of the criteria above.
aCML: atypical chronic myeloid leukemia; CML: chronic myeloid leukemia; CNL: chronic neutrophilic leukemia; ET: essential thrombocythemia; MPN: myeloproliferative neoplasm; PMF: primary myelofibrosis; PV: polycythemia vera; WHO: World Health Organization
* Cases of MPN, particularly those in accelerated phase and/or in post-polycythemic or post-essential thrombocythemic myelofibrosis, if neutrophilic, may simulate aCML. A previous history of MPN, the presence of MPN features in the bone marrow and/or MPN-associated mutations (in JAK2, CALR, or MPL) tend to exclude a diagnosis of aCML. Conversely, a diagnosis of aCML is supported by the presence of SETBP1 and/or ETNK1 mutations. The presence of a CSF3R mutation is uncommon in aCML and if detected should prompt a careful morphologic review to exclude an alternative diagnosis of CNL or other myeloid neoplasm.
Republished with permission of the American Society of Hematology, from Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016; 127:2391. Copyright © 2016; permission conveyed through Copyright Clearance Center, Inc.
Graphic 110230 Version 5.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟